SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $228,000 | +1.3% | 6,305 | 0.0% | 0.02% | -11.8% |
| Q4 2022 | $225,000 | +5.1% | 6,305 | -0.2% | 0.02% | -39.3% |
| Q3 2022 | $214,000 | -21.3% | 6,319 | -38.0% | 0.03% | -90.8% |
| Q3 2021 | $272,000 | -13.4% | 10,188 | 0.0% | 0.30% | -14.6% |
| Q2 2021 | $314,000 | +17.6% | 10,188 | 0.0% | 0.36% | +22.3% |
| Q1 2021 | $267,000 | -47.7% | 10,188 | -49.8% | 0.29% | -26.3% |
| Q4 2020 | $511,000 | -9.2% | 20,307 | -24.9% | 0.40% | +4.8% |
| Q3 2020 | $563,000 | -12.3% | 27,039 | -24.2% | 0.38% | -6.0% |
| Q1 2020 | $642,000 | +61.3% | 35,663 | +146.3% | 0.40% | +49.6% |
| Q3 2019 | $398,000 | – | 14,482 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |